Skip to main content
To the Editor: We have read with interest the letter of Dr. Chabrol and colleagues commenting on our recent documentation of cognitive impairment in adolescents with schizophrenia.
Clearly, it is important to clarify an issue that might confound a neuropsychological finding.
We disagree with the suggestion of Dr. Chabrol and colleagues that the statistically significant cognitive deficits in our group of adolescent patients are caused by medication side effects. First, we need to repeat that all of the patients in our study were stabilized on regimens of antipsychotic medications, a method that is commonly employed in studies of adult schizophrenic patients. We can add that there had been no recent changes in the medication regimen for the patients before cognitive testing.
Second, we are not aware of any study of effects of antipsychotic medication on cognition during adolescence. However, the literature on adults is large, highly relevant, and on balance, contradicts the suppositions of Chabrol and colleagues. Specifically, literature reviews of this topic make the following points:
1. Chronic administration of neuroleptic drugs does not generally impair neuropsychological functioning (1, 2).
2. Medication effects, if present, are transient and occur at the initiation of treatment (1).
3. Rather than worsen performance, chronic administration of neuroleptics improves performance on some tasks requiring sustained attention and visuomotor problem-solving skill (1).
For a review of earlier studies of structural neuroimaging and neuropsychological performance in adolescent patients with schizophrenia, see our 1995 article (3).
Finally, as clinical neuroscientists, we are much more focused on the empirical, factual basis of our assertion than on whether it evokes pessimism or optimism. As you know, this is the first controlled study of detailed neuropsychological function in teenagers with schizophrenia. We hope further studies will be performed to elucidate the full nature of these measures.

References

1.
Cassens G, Inglis AK, Appelbaum PS, Gutheil TG: Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients. Schizophr Bull 1990; 16:477–499
2.
Goldberg TE, Gold JM: Neurocognitive functioning in patients with schizophrenia: an overview, in Psychopharmacology—Fourth Generation of Progress. Edited by Bloom FE, Kupfer DJ. New York, Raven Press, 1995, pp 1245–1257
3.
Findling RL, Friedman L, Kenny J, Swales TP, Cola D, Schulz SC: Adolescent schizophrenia: methodologic review of the current neuroimaging and neuropsychologic literature. J Autism Dev Disord 1995; 25:627–639

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 498

History

Published online: 1 March 1999
Published in print: March 1999

Authors

Details

ROBERT L. FINDLING, M.D.
THOMAS P. SWALES, PH.D.
MILTON E. STRAUSS, PH.D.
JOHN A. JESBERGER, B.S.E.E.
S. CHARLES SCHULZ, M.D.
Cleveland, Ohio

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share